Evidence map›Paper›PMID 24380727›Full record

ReviewTrends in microbiology2014

Chaperone fusion proteins aid entropy-driven maturation of class II viral fusion proteins.

Peng Ge, Z Hong Zhou

Abstract readReview
In one paragraph

Review in Trends in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Peng GeDepartment of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles (UCLA), Los Angeles, CA 90095-7364, USA; California NanoSystems Institute, UCLA, Los Angeles, CA 90095-7227, USA.
Z Hong ZhouDepartment of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles (UCLA), Los Angeles, CA 90095-7364, USA; California NanoSystems Institute, UCLA, Los Angeles, CA 90095-7227, USA. Electronic address: Hong.Zhou@UCLA.edu.

Funding

Genome Structure, Transcription and Packaging of dsRNA VirusesR01AI094386 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Z Hong ZHOU · 2012 to 2026
$6.0M
High-Resolution CryoEM Reconstruction of Large ComplexesR01GM071940 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ZHOU, Z HONG · 2006 to 2025
$5.0M
STRUCTURAL STUDIES OF HUMAN CYTOMEGALOVIRUSR01AI046420 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ZHOU, Z HONG · 2000 to 2004
$1.1M
NIAID NIH HHS AI046420NIAID NIH HHS R01 AI046420NIAID NIH HHS R01 AI094386NIGMS NIH HHS GM071940NIGMS NIH HHS R01 GM071940
6 · The paper itself

Abstract

Class II viral fusion proteins are present on the envelope of flaviviruses and togaviruses, viruses that often cause tropical and subtropical diseases. These proteins use a second membrane protein as a molecular chaperone to assist their folding and to ensure proper function during viral assembly, maturation, and infection. Recent progress in structural studies of dengue viruses has revealed how the chaperone pre-membrane (prM) protein guides viral maturation and how pH is sensed in both the maturation and infection processes. Drastic conformation changes and reorganization of these viral membrane proteins occur during the transition from their metastable to stable structural states in a unidirectional, entropy-driven process.

Indexed as

EntropyProtein FoldingDengue VirusHydrogen-Ion ConcentrationMolecular ChaperonesProtein ConformationViral Envelope ProteinsViral Fusion ProteinsMolecular ChaperonesprM protein, FlavivirusViral Envelope ProteinsViral Fusion Proteinsbio-threat agentcryo-electron microscopyenveloped virusesflavivirusstructurestogavirus

Identifiers

PMID24380727
PMCPMC4445943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.